Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Melpomeni Kalofonou"'
Publikováno v:
Biosensors, Vol 14, Iss 9, p 443 (2024)
Current diagnostic and prognostic tests for prostate cancer require specialised laboratories and have low specificity for prostate cancer detection. As such, recent advancements in electrochemical devices for point of care (PoC) prostate cancer detec
Externí odkaz:
https://doaj.org/article/6d4eeda0723f4425ad61dc64fbed81a8
Autor:
Benjamin W. Wormald, Nicolas Moser, Nandita M. deSouza, Katerina-Theresa Mantikas, Kenny Malpartida-Cardenas, Ivana Pennisi, Thomas E. J. Ind, Katherine Vroobel, Melpomeni Kalofonou, Jesus Rodriguez-Manzano, Pantelis Georgiou
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Cervical cancer affects over half a million people worldwide each year, the majority of whom are in resource-limited settings where cytology screening is not available. As persistent human papilloma virus (HPV) infections are a key causative
Externí odkaz:
https://doaj.org/article/3e76db53a8814f40bddc0db2df6168c2
Autor:
Foteinos-Ioannis D. Dimitrakopoulos, Anna G. Antonacopoulou, Anastasia E. Kottorou, Melpomeni Kalofonou, Nikolaos Panagopoulos, Dimitrios Dougenis, Thomas Makatsoris, Vasiliki Tzelepi, Angelos Koutras, Haralabos P. Kalofonos
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmune system-related receptors CD40 (tumor necrosis factor receptor superfamily member 5), BAFFR (tumor necrosis factor receptor superfamily member 13C), and LTβR (tumor necrosis factor receptor superfamily member 3) play a pivotal role i
Externí odkaz:
https://doaj.org/article/c8a31c79958046baaea54e62931e3ee1
Autor:
Foteinos-Ioannis D. Dimitrakopoulos, Anna G. Antonacopoulou, Anastasia E. Kottorou, Nikolaos Panagopoulos, Fotini Kalofonou, Fotios Sampsonas, Chrisoula Scopa, Melpomeni Kalofonou, Angelos Koutras, Thomas Makatsoris, Dimitrios Dougenis, Helen Papadaki, Malcolm Brock, Haralabos P. Kalofonos
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Abstract A growing number of studies has shed light on the role of the NF-κΒ in non-small-cell lung cancer (NSCLC). To address the significance of major effectors of the NF-κΒ alternative pathway, we investigated the relationship between NF-κΒ2
Externí odkaz:
https://doaj.org/article/90d7b523d73d42dd8591096c779df15c
Classification of nucleic acid amplification on ISFET arrays using spectrogram-based neural networks
Autor:
Prateek Tripathi, Costanza Gulli, Joseph Broomfield, George Alexandrou, Melpomeni Kalofonou, Charlotte Bevan, Nicolas Moser, Pantelis Georgiou
The COVID-19 pandemic has highlighted a significant research gap in the field of molecular diagnostics. This has brought forth the need for AI-based edge solutions that can provide quick diagnostic results whilst maintaining data privacy, security an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b722fb8c55f98c0d556cc80ce7ca4d0
http://hdl.handle.net/10044/1/105101
http://hdl.handle.net/10044/1/105101
Autor:
Haralabos P. Kalofonos, Melpomeni Kalofonou, Anastasia E. Kottorou, Foteinos-Ioannis D. Dimitrakopoulos
Supplementary Table S2. Published studies on genetic variations of NF-κB family members and their clinical significance in NSCLC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b1c82c87ae3fcad35c49c464821cd3c
https://doi.org/10.1158/0008-5472.22425417.v1
https://doi.org/10.1158/0008-5472.22425417.v1
Autor:
Haralabos P. Kalofonos, Melpomeni Kalofonou, Anastasia E. Kottorou, Foteinos-Ioannis D. Dimitrakopoulos
Supplementary Figure S1. Hallmarks of lung cancer influenced by NF-κB activity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6210ba999de79b46629e6b6e33336338
https://doi.org/10.1158/0008-5472.22425423
https://doi.org/10.1158/0008-5472.22425423
Autor:
Haralabos P. Kalofonos, Melpomeni Kalofonou, Anastasia E. Kottorou, Foteinos-Ioannis D. Dimitrakopoulos
Thirty-four years since its discovery, NF-κB remains a transcription factor with great potential for cancer therapy. However, NF-κB–targeted therapies have yet to find a way to be clinically translatable. Here, we focus exclusively on the role of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862f11defaddefc1eeefd9caa436adb8
https://doi.org/10.1158/0008-5472.c.6512031.v1
https://doi.org/10.1158/0008-5472.c.6512031.v1
Autor:
Joseph Broomfield, Melpomeni Kalofonou, Thomas Pataillot-Meakin, Sue M. Powell, Nicolas Moser, Charlotte L. Bevan, Pantelis Georgiou
Prostate cancer (PCa) is the second most common cause of male cancer-related death worldwide. The gold standard of treatment for advanced PCa is androgen deprivation therapy (ADT). However, eventual failure of ADT is common and leads to lethal metast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f107b2e415e14c10f97a9e91bcb24400
https://doi.org/10.1101/2022.08.04.502773
https://doi.org/10.1101/2022.08.04.502773
Autor:
George Alexandrou, Katerina-Theresa Mantikas, Simak Ali, Melpomeni Kalofonou, Pantelis Georgiou, Jacqui Shaw, C. Toumazou, Nicolas Moser, Jesus Rodriguez-Manzano, R. Charles Coombes
Publikováno v:
IEEE Transactions on Biomedical Circuits and Systems. 15:380-389
ESR1 mutations are important biomarkers in metastatic breast cancer. Specifically, p.E380Q and p.Y537S mutations arise in response to hormonal therapies given to patients with hormone receptor positive (HR+) breast cancer (BC). This paper demonstrate